John Paul DeJoria - 31 Dec 2025 SCHEDULE 13G/A Report for Telomir Pharmaceuticals, Inc. Common Stock, no par value (TELO)

Filing Manager: John Paul DeJoria
Reporting Manager: John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity
Security: Telomir Pharmaceuticals, Inc. Common Stock, no par value
Symbol: TELO
Shares outstanding: 34,382,284 shares
Disclosed Ownership: 3,245,000 shares
Ownership: 9.4%
Form type: SCHEDULE 13G/A
Filing time: 12 Feb 2026, 21:24:50 UTC
Date of event: 31 Dec 2025
Previous filing: 18 Sep 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity	9.4%	3,245,000	3,245,000	0	/s/ Matthew R. Bair	Matthew R. Bair, Attorney-in-Fact